Max Healthcare Institute Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,569 Cr +20.3% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
MH

Max Healthcare Institute Ltd

Q3 FY26Healthcare Services

Max Healthcare Institute Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹2,068Cr
+10.7% YoY
−3.1% QoQ
Net profit
₹301Cr
+25.9% YoY
−38.7% QoQ
Margin
26%
−1 pp YoY
−1 pp QoQ
Price₹1,000
Market cap₹98.2K Cr
P/E65.6

The short version

Network gross revenue grew 19% YoY in nine months ended Dec 2025, indicating strong growth momentum. Growth is expected to resume strongly from Q4 FY '26 onwards as capacity constraints ease and new hospital beds come online.

From Max Healthcare Institute Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Network gross revenue grew 19% YoY in nine months ended Dec 2025, indicating strong growth momentum.
  • Existing beds are growing at low teens percentage rates, partly due to higher onco share and advanced services like robotics.
  • Capacity additions have faced minor delays but are expected to drive growth once operational (e.g., Dwarka expansion by 260 beds, Gurgaon hospital commissioning by H1 FY '27, Zirakpur by FY '28).
  • Institutional patient mix increased temporarily due to insurance disruptions but is normalizing, with cashless services restored.
  • ARPOB growth is moderate (3% YoY), reflecting stable pricing with medical inflation in low single digits.

2 more points from Max Healthcare Institute Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current capex run rate is roughly INR 400-450 crore per quarter.
  • FY '26 capex target is around INR 1,900 crore; the company is on track to meet this.
  • Capex is mostly back-ended, with conservative projections to avoid project delays due to financial closure.
  • Capex plans will be revisited by end of March 2025 with possible updates.
  • Incremental beds being commissioned are EBITDA and margin accretive, improving future cash flows.
  • Expansion projects underway:
  • Max Lucknow increasing capacity from 413 to ~500 beds by FY '26-end.
  • Gurgaon 500-bed hospital expected first phase commissioning by end H1 FY '27.
  • 100 beds at Nagpur with civil work started, targeted completion in 24 months.
  • 400 beds at Zirakpur (Mohali) on track for FY '28 commission.
  • 200 beds at Max Vaishali awaiting approvals, completion within 24 months post-approval.

2 more points from Max Healthcare Institute Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Max Healthcare Institute Ltd said on order book & pipeline — free account, 30 seconds.

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Max Healthcare Institute Ltd Q3 FY26 results — key figures

Max Healthcare Institute Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue2,0681,868+10.7%2,135-3.1%
Operating profit (EBITDA)538499+7.8%575-6.4%
Operating margin26%27%-1 pp27%-1 pp
Profit before tax365309+18.1%446-18.2%
Net profit (PAT)301239+25.9%491-38.7%
EPS (₹)3.092.46+25.6%5.05-38.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q3 FY26)

    FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnostic Centre's Q3 FY26 earnings call —

  • Aster DM Quality (Q3 FY26)

    Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…

  • Chandan Healthca (Q3 FY26)

    The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…

  • Rainbow Childrens Medicare (Q3 FY26)

    Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q3 FY26 results?

Network gross revenue grew 19% YoY in nine months ended Dec 2025, indicating strong growth momentum. Growth is expected to resume strongly from Q4 FY '26 onwards as capacity constraints ease and new hospital beds come online.

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare Institute Ltd planning capital expenditure?

Current capex run rate is roughly INR 400-450 crore per quarter.

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.